Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 6/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22044355 | 0.90 | SMN1; SMN2 (0.46) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 | |
| SCHEMBL11020376 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 | |
| SCHEMBL22044370 | 0.83 | SMN1; SMN2 (0.49) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 | |
| SCHEMBL22050632 | 0.79 | ALDH1A1 (0.45) | SMN1; SMN2CYP3A4KIF11ESR1ESR2 | |
| SCHEMBL10686605 | 0.78 | ESR1 (0.45) | SMN1; SMN2TDP1CYP3A4ALOX15ESR1 | |
| SCHEMBL22051104 | 0.78 | ESR1 (0.44) | SMN1; SMN2CYP3A4KIF11ESR1ESR2 | |
| SCHEMBL22051862 | 0.77 | HSD17B10 (0.45) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 | |
| SCHEMBL22050375 | 0.77 | KIF11 (0.45) | SMN1; SMN2TDP1CYP3A4THRBKIF11 | |
| SCHEMBL33608 | 0.76 | SMN1; SMN2 (0.63) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 | |
| SCHEMBL22050398 | 0.76 | SMN1; SMN2 (0.42) | SMN1; SMN2TDP1CYP3A4ALOX15TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-06-04 | — | — | US | disclosed |
| EP-3659996-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN, AND CURED PRODUCT | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | PAM, CBR1, KDM1A | SMN1; SMN2 958/4885TDP1 2589/4885CYP3A4 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.